The Global Defibrillators Market was valued at USD 9.76 billion in 2016 and is projected to reach USD 17.76 billion by 2025, growing at a CAGR of 6.88% from 2017 to 2025.
Atrial chokes and blockages is becoming a common problem for todays healthcare services. The key factor driving the market and pushing it to grow is the growth in geriatric population as well as lifestyle changes and habits.
Sample Infographics:
Market Dynamics:
1. Market Drivers
1.1 Technological developments in the medical technology
1.2 Growing cases of cardiovascular diseases
1.3 Growing Geriatric population
1.4 Focus on making defibrillators more accessible
2. Market Restraints
2.1 Less awareness
2.2 Risks associated with External defibrillators
2.3 Stringent regulations in the U.S.
Market Segmentation:
1. Global Defibrillators Market, by End User:
1.1 Hospitals, Clinics, & Cardiac Centers
1.2 Pre-Hospitals
1.3 Public Access Markets
1.4 Home Care
1.5 Alternate Care Markets
2. Global Defibrillators Market, by Product:
2.1 Implantable Cardioverter Defibrillators (ICDS)
2.1.1 Implantable Cardioverter Defibrillators (T-ICDS)
2.1.1.1 Biventricular ICDS/Cardiac Resynchronization Therapy Defibrillators (CRT-DS)
2.1.1.2 Dual-Chamber ICDS
2.1.1.3 Single-Chamber ICDS
2.1.2 Subcutaneous Implantable Cardioverter Defibrillators (S-ICDS)
2.2 External Defibrillators
2.2.1 Automated External Defibrillators (AEDS)
2.2.1.1 Semi-Automated External Defibrillators
2.2.1.2 Fully Automated External Defibrillators
2.3 Manual External Defibrillators
2.4 Wearable Cardioverter Defibrillators (WCDS)
3. Global Defibrillators Market, by Region:
3.1 North America (U.S., Canada, Mexico)
3.2 Europe (Germany, UK, France, Rest of Europe)
3.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
3.4 Latin America (Brazil, Argentina, Rest of Latin America)
3.5 Middle East & Africa
Competitive Landscape:
The major players in the market are as follows:
1. Medtronic PLC
2. St. Jude Medical, Inc.
3. Boston Scientific Corporation
4. Philips Healthcare (A Division of Koninklijke Philips N.V.)
5. Zoll Medical Corporation (A Subsidiary of Asahi Kasei Corporation)
6. Biotronik Se & Co.Kg
7. Physio-Control International, Inc.
8. Cardiac Science Corporation (A Portfolio Company of Aurora Capital Group)
9. Sorin Group (Now Livanova PLC)
10. Nihon Kohden Corporation
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Defibrillators Market was performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.
1 INTRODUCTION OF GLOBAL DEFIBRILLATORS MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL DEFIBRILLATORS MARKET OUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework
5 Global Defibrillators Market, by End User:
5.1 Hospitals, Clinics, & Cardiac Centers
5.2 Pre-Hospitals
5.3 Public Access Markets
5.4 Home Care
5.5 Alternate Care Markets
6 Global Defibrillators Market, by Product:
6.1 Implantable Cardioverter Defibrillators (ICDS)
6.1.1 Implantable Cardioverter Defibrillators (T-ICDS)
6.1.1.1 Biventricular ICDS/Cardiac Resynchronization Therapy Defibrillators (CRT-DS)
6.1.1.2 Dual-Chamber ICDS
6.1.1.3 Single-Chamber ICDS
6.1.2 Subcutaneous Implantable Cardioverter Defibrillators (S-ICDS)
6.2 External Defibrillators
6.2.1 Automated External Defibrillators (AEDS)
6.2.1.1 Semi-Automated External Defibrillators
6.2.1.2 Fully Automated External Defibrillators
6.3 Manual External Defibrillators
6.4 Wearable Cardioverter Defibrillators (WCDS)
7 GLOBAL DEFIBRILLATORS MARKET, BY GEOGRAPHY
7.1 Overview
7.2 North America Regional Market Estimates and Forecasts, 2012 - 2025
7.2.1 U.S.
7.2.2 Canada
7.2.3 Mexico
7.3 Europe Regional Market Estimates and Forecasts, 2012 - 2025
7.3.1 Germany
7.3.2 U.K.
7.3.3 France
7.3.4 Rest of Europe
7.4 Asia Pacific Regional Market Estimates and Forecasts, 2012 - 2025
7.4.1 China
7.4.2 Japan
7.4.3 India
7.4.4 Rest of Asia Pacific
7.5 Latin America Regional Market Estimates and Forecasts, 2012 - 2025
7.5.1 Brazil
7.5.2 Argentina
7.6 Rest of the World Regional Market Estimates and Forecasts, 2012 â€" 2025
8 GLOBAL DEFIBRILLATORS MARKETCOMPETITIVE LANDSCAPE
8.1 Overview
8.2 Company Market Share
8.3 Vendor Landscape
8.4 Key Development Strategies
9 COMPANY PROFILES
9.1 Medtronic PLC
9.1.1 Overview
9.1.2 Financial Performance
9.1.3 Product Outlook
9.1.4 Key Developments
9.2 St. Jude Medical, Inc.
9.2.1 Overview
9.2.2 Financial Performance
9.2.3 Product Outlook
9.2.4 Key Developments
9.3 Boston Scientific Corporation
9.3.1 Overview
9.3.2 Financial Performance
9.3.3 Product Outlook
9.3.4 Key Developments
9.4 Philips Healthcare
9.4.1 Overview
9.4.2 Financial Performance
9.4.3 Product Outlook
9.4.4 Key Developments
9.5 Zoll Medical Corporation
9.5.1 Overview
9.5.2 Financial Performance
9.5.3 Product Outlook
9.5.4 Key Developments
9.6 Biotronik Se & Co.Kg
9.6.1 Overview
9.6.2 Financial Performance
9.6.3 Product Outlook
9.6.4 Key Developments
9.7 Physio-Control International, Inc.
9.7.1 Overview
9.7.2 Financial Performance
9.7.3 Product Outlook
9.7.4 Key Developments
9.8 Cardiac Science Corporation
9.8.1 Overview
9.8.2 Financial Performance
9.8.3 Product Outlook
9.8.4 Key Developments
9.9 Sorin Group
9.9.1 Overview
9.9.2 Financial Performance
9.9.3 Product Outlook
9.9.4 Key Developments
9.10 Nihon Kohden Corporation
9.10.1 Overview
9.10.2 Financial Performance
9.10.3 Product Outlook
9.10.4 Key Developments
10 Appendix
10.1 Related Reports
Market Overview
The Asia Pacific Cardiac Rhythm Management Devices Market is set to witness substantial growth over the forecast period, driven by a surge in the prevalence of cardiovascular diseases, technological advancements, and increasing healthcare expenditure across the region. T...
Market Overview
The Europe Cardiac Rhythm Management Devices Market is poised for substantial growth over the next decade, fueled by the increasing prevalence of cardiovascular diseases, technological advancements, and a growing geriatric population. The market will reach a valuation of...
Market Overview
The North America Cardiac Rhythm Management Devices Market is on a trajectory of remarkable growth over the next decade, propelled by the increasing prevalence of cardiovascular diseases, continuous technological advancements, and the rising adoption of minimally invasiv...
Market Overview
The Global Cardiac Rhythm Management Devices Market is poised for significant growth in the coming decade, driven by rising incidences of cardiovascular diseases, technological advancements in medical devices, and an increasing aging population. The Global Cardiac Rhythm...
The global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impa...
The global Defibrillators Pads market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this ...
The global Medical Implantable Defibrillators market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market p...
The global Subcutaneous Implantable Defibrillators market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help mar...
The global Veterinary External Defibrillators market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market p...
Overview of the Global Automatic External Defibrillators Market:
The report discusses everything a marketer requires before investing in the global Automatic External Defibrillators Market during the forecast period...